CLINICAL_TRIALS
trial_result
· 2015-08-06
Clinical Trial Update: Lisdexamfetamine Dimesylate 2-year Safety Study in Children and Adolescents With Attention-Deficit/Hyperactivity Disorder (ADHD) [Phase 4]
Summary
Phase 4 safety study updating on long-term lisdexamfetamine dimesylate use in children and adolescents with ADHD; results posted in 2015.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Shire | Conditions: Attention Deficit Hyperactivity Disorder (ADHD) | Phase 4 | Status: COMPLETED | Results posted: 2015-08-06